ReviewFrontiers in pharmacology2025
The western transmission of traditional Chinese medicine: an investigation of the cultural elements of traditional Chinese medicine in biomedical systems of cross-Asia countries.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bridging the epistemic gap: a psychological acceptance model for the cross-cultural health communication of traditional Chinese medicine.Frontiers in public health · 2026Article
- Unveiling the pathways of Xuanbai Chengqi Decoction in obese asthma: from immune modulation to microbial restoration.Frontiers in nutrition · 2026Article
- Danggui Buxue Decoction attenuates 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer growth in A/J mice by suppressing HIF-1α/VEGF-mediated angiogenesis.Frontiers in medicine · 2025Article
- Addressing the obstacles in cultivating global advocates for traditional Chinese medicine: qualitative perspectives from stakeholder interview analysis.Frontiers in public health · 2025Article
- Developing a value assessment index system of anti-tumour commercial Chinese polyherbal preparation in China: a modified Delphi study.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The globalization of Traditional Chinese Medicine (TCM) has facilitated its integration into healthcare systems beyond China, particularly in cross-Asia countries such as Japan, Korea, and Vietnam, while influencing biomedical practices worldwide. This review explores the cultural, historical, and scientific dimensions of TCM's transmission, focusing on how its foundational theories (e.g., Yin-Yang, Qi-Blood, and Five Elements) and practices (e.g., acupuncture, herbal formulations) have been adapted and validated in diverse sociocultural contexts. We analysed primary literature from data collected by PubMed, Google Scholar, CNKI, Web of Science, Bing, Baidu, and Scopus (1990-2024). Our review critically evaluates the scientific evidence supporting TCM-derived bioactive metabolites like artemisinin from Artemisia annua L. [Asteraceae] and berberine from Coptis chinensis Franch. [Ranunculaceae], examining their concentrations, bioavailability, and clinical applications. Challenges such as standardization, intellectual property disputes, and cultural reinterpretation are critically evaluated. This paper systematically argues that TCM's cross-cultural transmission reflects a dynamic interplay between tradition and modern biomedicine, offering a model for integrating traditional knowledge into global healthcare while highlighting the limitations of current research and areas requiring further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.